Familial Partial Lipodystrophy, Type 3

Known as: FPLD3, Lipodystrophy, Familial Partial, Associated With PPARg Mutations, Lipodystrophy, Familial Partial, Type 3 
This type can be caused by mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2016
01220042016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
1. DISEASE CHARACTERISTICS 1.1 Name of the disease (synonyms) There are several subclasses of familial partial lipodystrophy… (More)
Is this relevant?
2016
2016
OBJECTIVE Familial partial lipodystrophy type 3 (FPLD3) is an autosomal dominant disorder with loss of subcutaneous adipose… (More)
Is this relevant?
2012
2012
The peroxisome proliferator-activated receptor protein gamma (PPARγ), a nuclear receptor involved in adipocyte differentiation… (More)
Is this relevant?
2007
2007
The nuclear receptor peroxisome proliferator-activated receptor (PPAR) gamma plays a key role in the regulation of glucose and… (More)
Is this relevant?
2007
2007
BACKGROUND Lipodystrophies are characterized by redistributed subcutaneous fat stores. We previously quantified subcutaneous fat… (More)
  • table 1
  • table 2
Is this relevant?
2007
2007
CONTEXT Familial partial lipodystrophy (FPLD) results from coding sequence mutations either in LMNA, encoding nuclear lamin A/C… (More)
Is this relevant?
2005
2005
Familial partial lipodystrophy (Dunnigan) type 3 (FPLD3, Mendelian Inheritance in Man [MIM] 604367) results from heterozygous… (More)
Is this relevant?
2005
2005
Familial partial lipodystrophy (FPLD) is characterized by adipose tissue repartitioning with multiple metabolic disturbances… (More)
Is this relevant?
2004
2004
Familial partial lipodystrophy (FPLD) results from coding sequence mutations either in LMNA, encoding nuclear lamin A/C, or in… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?